LENZ Therapeutics, Inc.
4.10%
1,183,543
1815776
52635N103
Sep 17, 2025
Sep 22, 2025, 04:20 PM
Reporting Persons (9)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | Partnership | 4.10% | 1,183,543 | 1,183,543 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 4.10% | 1,183,543 | 0 | 1,183,543 |
| Versant Ventures VI GP-GP, LLC | Other | 4.10% | 1,183,543 | 0 | 1,183,543 |
| Versant Ventures VII GP-GP, LLC | Other | 3.20% | 926,691 | 0 | 926,691 |
| Versant Venture Capital VII, L.P. | Partnership | 3.20% | 926,691 | 926,691 | 0 |
| Versant Ventures VII GP, L.P. | Partnership | 3.20% | 926,691 | 0 | 926,691 |
| Versant Vantage II, L.P. | Partnership | 3.00% | 842,162 | 842,162 | 0 |
| Versant Vantage II GP, L.P. | Partnership | 3.00% | 842,162 | 0 | 842,162 |
| Versant Vantage II GP-GP, LLC | Other | 3.00% | 842,162 | 0 | 842,162 |
Disclosure Items (2)
Common Stock, par value $0.00001 per share
LENZ Therapeutics, Inc.
201 Lomas Santa Fe Dr., Solana Beach, CA, 92075
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On August 22, 2025, Versant VI sold 26,161 shares of Common Stock at a price per share of $40.1513 for aggregate proceeds of approximately $1,050,398.16. On August 22, 2025, Versant VII sold 12,885 shares of Common Stock at a price per share of $40.1513 for aggregate proceeds of approximately $517,349.50. On August 25, 2025, Versant VI sold 52,419 shares of Common Stock at a price per share of $39.5417 for aggregate proceeds of approximately $2,072,736.37. On August 25, 2025, Versant VII sold 25,818 shares of Common Stock at a price per share of $39.5417 for aggregate proceeds of approximately $1,020,887.61. On August 26, 2025, Versant VI sold 47,443 shares of Common Stock at a price per share of $39.0129 for aggregate proceeds of approximately $1,850,889.01. On August 26, 2025, Versant VII sold 23,368 shares of Common Stock at a price per share of $39.0129 for aggregate proceeds of approximately $911,653.45. On September 18, 2025, Versant VI sold 90,654 shares of Common Stock at a price per share of $42.2335 for aggregate proceeds of approximately $3,828,631.71. On September 18, 2025, Versant VII sold 44,650 shares of Common Stock at a price per share of $42.2335 for aggregate proceeds of approximately $1,885,723.80.